Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis

Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice

(2011) Grant W. Cannon et al.   ARTHRITIS CARE & RESEARCH

Persistence and switching patterns among women with varied osteoporosis medication histories: 12-month results from POSSIBLE US™

(2010) A. N. A. Tosteson et al.   OSTEOPOROSIS INTERNATIONAL

Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry

(2010) T. R. Mikuls et al.   RHEUMATOLOGY

Medication adherence, first episode duration, overall duration and time without therapy: the example of bisphosphonates

(2009) Elizabeth E. Roughead et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Persistence of weekly alendronate: a real-world study in Croatia

(2008) Simeon Grazio et al.   CLINICAL RHEUMATOLOGY

Benefit of Adherence With Bisphosphonates Depends on Age and Fracture Type: Results From an Analysis of 101,038 New Bisphosphonate Users

(2008) Jeffrey R Curtis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence

(2008) C. Roerholt et al.   OSTEOPOROSIS INTERNATIONAL